Persones / Equip Humà

Angel Montero Carcaboso

Buscador de publicacions

Publicacions

  • Gomez-Gonzalez S, Garrido- García A, García-Gerique L, Lemos I, Suñol M, de Torres C, Kulis M, Pérez-Jaume S, Carcaboso AM, Luu B, Kieran MW, Jabado N, Kozlenkov A, Dracheva S, Ramaswamy V, Hovestadt V, Johann P, Jones DTW, Pfister SM, Morales-La Madrid A, Cruz-Martínez O, Taylor MD, Martín-Subero JI, Mora J and Lavarino C.

    A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma

    CLINICAL CANCER RESEARCH . 24(6): 1355-1363. Nº de cites: 22

    [doi:10.1158/1078-0432.CCR-17-2243]

  • Prieto C, López-Millán B, Roca-Ho H, Stam RW, Romero-Moya D, Rodríguez-Baena FJ, Sanjuan-Pla A, Ayllón V, Ramírez M, Bardini M, De Lorenzo P, Valsecchi MG, Stanulla M, Iglesias M, Ballerini P, Carcaboso AM, Mora J, Locatelli F, Bertaina A, Padilla L, Rodríguez-Manzaneque JC, Bueno C and Menéndez P.

    NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

    Leukemia . 32(3): 633-644. Nº de cites: 30

    [doi:10.1038/leu.2017.294]

  • Tsoli M, Liu J, Franshaw L, Shen H, Cheng C, Jung M, Joshi S, Ehteda A, Khan A, Carcaboso AM, Dilda PJ, Hogg P and Ziegler DS.

    Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma.

    Oncotarget . 9(7): 7541-7556. Nº de cites: 27

    [doi:10.18632/oncotarget.24045]

  • Mack SC, Pajtler KW, Chavez L, Okonechnikov K, Bertrand KC, Wang X, Erkek S, Federation A, Song A, Lee C, Wang X, McDonald L, Morrow JJ, Saiakhova A, Sin-Chan P, Wu Q, Michaelraj KA, Miller TE, Hubert CG, Ryzhova M, Garzia L, Donovan L, Dombrowski S, Factor DC, Luu B, Valentim CLL, Gimple RC, Morton A, Kim L, Prager BC, Lee JJY, Wu X, Zuccaro J, Thompson Y, Holgado BL, Reimand J, Ke SQ, Tropper A, Lai S, Vijayarajah S, Doan S, Mahadev V, Minan AF, Grobner SN, Lienhard M, Zapatka M, Huang Z, Aldape KD, Carcaboso AM, Houghton PJ, Keir ST, Milde T, Witt H, Li Y, Li CJ, Bian XW, Jones DTW, Scott I, Singh SK, Huang A, Dirks PB, Bouffet E, Bradner JE, Ramaswamy V, Jabado N, Rutka JT, Northcott PA, Lupien M, Lichter P, Korshunov A, Scacheri PC, Pfister SM, Kool M, Taylor MD and Rich JN.

    Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling

    Nature . 553(7686): 101-105. Nº de cites: 158

    [doi:10.1038/nature25169]

  • Chheda ZS, Kohanbash G, Okada K, Jahan N, Sidney J, Pecoraro M, Yang X, Carrera DA, Downey KM, Shrivastav S, Liu S, Lin Y, Lagisetti C, Chuntova P, Watchmaker PB, Mueller S, Pollack IF, Rajalingam R, Carcaboso AM, Mann M, Sette A, Garcia KC, Hou Y and Okada H.

    Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy

    JOURNAL OF EXPERIMENTAL MEDICINE . 215(1): 141-157. Nº de cites: 171

    [doi:10.1084/jem.20171046]

  • Pascual-Pastó G, Gene-Olaciregui N, Opezzo JAW, Castillo-Ecija H, Cuadrado-Vilanova M, Paco-Mercader S, Rivero EM, Vilà-Ubach M, Restrepo-Perdomo CA, Torrebadell-Burriel M, Suñol M, Schaquevich P, Mora J, Bramuglia GF, Chantada G and Carcaboso AM.

    Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier

    JOURNAL OF CONTROLLED RELEASE . 264: 34-44. Nº de cites: 13

    [doi:10.1016/j.jconrel.2017.08.018]

  • Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng HK, Li X, Mu K, Trabelsi S, Brahim DH, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Suñol M, de Torres C, Cruz-Martínez O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily MA, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, von Bueren AO, Baudis M, Resnick A and Jones C.

    Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

    Cancer Cell . 32(4): 520-537. Nº de cites: 692

    [doi:10.1016/j.ccell.2017.08.017]

  • Boeva V, Louis-Brennetot C, Peltier A, Durand S, Pierre-Eugène C, Raynal V, Etchevers HC, Thomas S, Lermine A, Daudigeos-Dubus E, Geoerger B, Orth MF, Grünewald TGP, Diaz E, Ducos B, Surdez D, Carcaboso AM, Medvedeva I, Deller T, Combaret V, Lapouble E, Pierron G, Grossetête-Lalami S, Baulande S, Schleiermacher G, Barillot E, Rohrer H, Delattre O and Janoueix-Lerosey I.

    Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries

    NATURE GENETICS . 49(9): 1408-1413. Nº de cites: 291

    [doi:10.1038/ng.3921]

  • Cockle JV, Brüning-Richardson A, Scott KJ, Thompson J, Kottke T, Morrison E, Ismail A, Carcaboso AM, Rose A, Selby P, Conner J, Picton S, Short S, Vile R, Melcher A and Ilett E.

    Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion

    MOLECULAR THERAPY-ONCOLYTICS . 5: 75-86. Nº de cites: 22

    [doi:10.1016/j.omto.2017.04.002]

  • Haque F, Varlet P, Puntonet J, Storer L, Bountali A, Rahman R, Grill J, Carcaboso AM, Jones C, Layfield R and Grundy RG.

    Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours

    Acta neuropathologica communications . 5: 45-45. Nº de cites: 28

    [doi:10.1186/s40478-017-0449-1]